切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Valosin-containing protein (VCP) - Subtilisin/Kex2p-like proprotein convertase - adrenoceptor - Inward Rectifier Potassium (Kir) Channels

10 件产品

每页
清除全部
  1. CGP 20712 dihydrochloride
    B6552 CGP 20712 dihydrochloride
    Target: adrenoceptor
    Summary: β1拮抗剂
      ≥16.25 mg/mL
  2. Decanoyl-RVKR-CMK
    B5437 Decanoyl-RVKR-CMK
    Target: Subtilisin/Kex2p-like proprotein convertase
    Summary: 枯草杆菌蛋白酶/Kex2p样前蛋白转化酶抑制剂
      Soluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. NMS-873
    B2168 NMS-873
     3 Citation
    Target: Valosin-containing protein (VCP)
    Summary: VCP/p97抑制剂
      ≥17.1 mg/mL
      insoluble in H2O
  8. Mirabegron (YM178)
    A8474 Mirabegron (YM178)
    中文名: 米拉贝隆
    Target: adrenoceptor
    Summary: 选择性β3肾上腺素受体激动剂
      ≥19.83 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页